Skip to content
People

Matthew Angel

President and Chief Executive Officer at Tempest Therapeutics.

Earliest Form D on file: Apr 2026

Tempest Therapeutics

Biotech, Brisbane CA

President and Chief Executive Officer · signer

  • Signed
  • Named
  • Size is amount sold

Filings

3
  • Oct 13, 2026

    Option to acquire, security to be acquired, other, signed · Form D

    $7.5M

    of $7.5M

  • Jun 23, 2026

    Equity, option to acquire, security to be acquired, other, signed · Form D

    $4.1M

    of $4.1M

  • Apr 3, 2026

    Equity, option to acquire, security to be acquired, signed · Form D

    $2M

    of $2M

Network

At Tempest Therapeutics

11 people

5 more at Tempest Therapeutics